Peter Ciznar

Bratislava, BL, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Impact of 22q11.2 deletion syndrome on clinical and immunological status of infants with conotruncal heart defects.

Impact of 22q11.2 deletion syndrome on clinical and immunological status of infants with conotruncal heart defects.

Journal: Cardiology in the young

Published: January 22, 2026

Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.

Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 17, 2025

Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Journal: Journal of clinical immunology

Published: October 09, 2025

Impact of immunodeficiencies on immunity induced by SARS-CoV-2 infection, mRNA BNT162b2 vaccination, and their combination in children and young adults.

Impact of immunodeficiencies on immunity induced by SARS-CoV-2 infection, mRNA BNT162b2 vaccination, and their combination in children and young adults.

Journal: Frontiers in immunology

Published: July 07, 2025

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study.

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study.

Journal: Blood advances

Published: February 07, 2025

Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Journal: Journal of clinical immunology

Published: December 17, 2024

fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.

fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: March 08, 2024

Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival.

Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival.

Journal: Blood

Published: July 10, 2023

Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Journal: The Journal of allergy and clinical immunology

Published: April 08, 2023

Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death.

Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death.

Journal: The Journal of clinical investigation

Published: March 29, 2023

Severe congenital T-lymphocytopenia may affect the outcome of neonatal intensive care.

Severe congenital T-lymphocytopenia may affect the outcome of neonatal intensive care.

Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Published: February 06, 2023

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Journal: Nature

Published: December 05, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026